SA
Sign upLog In

Pulmonx Corp (LUNG)

Cost of Revenue

$20.06M

TTM · Period ending: · USD

LUNG logo

LUNG Cost of Revenue

Latest reported$20.06M
LUNG TTM Cost of Revenue ($10.36M → $20.06M)
High-resolution chart · PNG

LUNG cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pulmonx Corp Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
20,063,000
21,704,000
23,358,000
24,476,000
24,387,000
23,208,000
21,888,000
20,691,000
19,969,000
18,953,000
18,023,000
17,286,000
15,997,000
15,069,000
13,797,000
13,013,000
13,185,000
12,827,000
12,786,000
12,081,000
11,709,000
11,196,000
11,531,000
11,789,000
11,336,000
11,088,000
10,357,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.